<DOC>
	<DOCNO>NCT02612844</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate Safety , Tolerability , Pharmacokinetics ( exposure trial drug body ) Pharmacodynamics ( effect investigate drug body ) subcutaneous NNC0143-0406 A 0.6 mmol/L Subjects Type 1 Diabetes</brief_summary>
	<brief_title>A Trial Investigating Safety , Tolerability , Pharmacokinetics Pharmacodynamics Subcutaneous NNC0143-0406 A 0.6 mmol/L Subjects With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Male , age 1855 year ( inclusive ) time sign informed consent Subjects diagnose ( clinically ) type 1 diabetes mellitus least 365 day prior day screen Body mass index 18.5 28.0 kg/m^2 ( inclusive ) Known suspect hypersensitivity trial product ( ) relate product . Males sexually active surgically sterilise ( vasectomy otherwise ) partner use highly effective contraception method , randomisation 90 day dose , double barrier contraception ( e.g . condom spermicide ) combination either oral contraceptive , contraceptive patch , diaphragm intrauterine device , together physical barrier condom . Malesubjects must also agree refrain sperm donation randomisation 90 day dose History presence clinically relevant respiratory , metabolic ( include dyslipidaemia ) , renal , hepatic , gastrointestinal , endocrinological condition ( except condition associate diabetes mellitus ) Subject donate blood plasma past month 500 mL within 90 day prior screen Smoker ( define subject smoke 5 cigarette equivalent per day ) able willing refrain smoking use nicotine gum transdermal nicotine patch inpatient period Recurrent severe hypoglycaemia ( 1 severe hypoglycaemic event past 180 day ) hypoglycaemic unawareness judge investigator hospitalisation diabetic ketoacidosis within last 180 day</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>